Alkermes (ALKS) Share-based Compensation (2010 - 2026)

Alkermes (ALKS) reported Share-based Compensation of $36.3 million for Q1 2026, up 59.27% year-over-year from $22.8 million in Q1 2025, and up 38.27% quarter-over-quarter from $26.3 million in Q4 2025.

Alkermes (ALKS) Share-based Compensation (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Share-based Compensation data on file, last reported at $36.3 million in Q1 2026.

  • Share-based Compensation for Q1 2026 came in at $36.3 million, up 59.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $75.6 million (up 35.57% YoY), and the FY2025 annual result was $98.7 million, up 2.15% from the prior year.
  • Share-based Compensation rose to $36.3 million in Q1 2026 per ALKS's latest filing, from $26.3 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $36.3 million in Q1 2026 and troughed at $6.0 million in Q2 2024.
  • A 5-year average of $21.1 million and a median of $23.4 million in 2022 frame the typical range for Share-based Compensation.
  • The sharpest annual moves came in 2024 and 2026: Share-based Compensation sank 78.88% in 2024, then surged 59.27% in 2026.
  • A 5-year view of Share-based Compensation shows it stood at $26.5 million in 2022, then slipped by 2.42% to $25.8 million in 2023, then declined by 19.72% to $20.7 million in 2024, then grew by 26.64% to $26.3 million in 2025, then surged by 38.27% to $36.3 million in 2026.
  • Business Quant data shows ALKS's Share-based Compensation at $36.3 million in Q1 2026, $26.3 million in Q4 2025, and $6.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 43.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 25.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 33.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -395,114.54
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 57.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 21.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 36.33 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 16.04 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 36.86 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 9.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 36.33 Mn
Mar 31, 2026 36.33 Mn
Dec 31, 2025 26.28 Mn
Dec 31, 2025 26.28 Mn
Sep 30, 2025 6.44 Mn
Sep 30, 2025 6.44 Mn
Jun 30, 2025 6.51 Mn
Jun 30, 2025 6.51 Mn
Mar 31, 2025 22.81 Mn
Mar 31, 2025 22.81 Mn
Dec 31, 2024 20.75 Mn
Dec 31, 2024 20.75 Mn
Sep 30, 2024 6.15 Mn
Sep 30, 2024 6.15 Mn
Jun 30, 2024 6.02 Mn
Jun 30, 2024 6.02 Mn
Mar 31, 2024 32.76 Mn
Mar 31, 2024 32.76 Mn
Dec 31, 2023 25.84 Mn
Dec 31, 2023 25.84 Mn